71 results
8-K
EX-99.1
MCRB
Seres Therapeutics, Inc.
26 Sep 24
To Nestlé Health Science; Sale Expected to Close on September 30
4:13pm
, subject to the satisfaction of customary closing conditions.
About Seres Therapeutics
Seres Therapeutics, Inc. (Nasdaq: MCRB) is a clinical-stage
DEFM14A
MCRB
Seres Therapeutics, Inc.
26 Aug 24
Proxy related to merger
4:36pm
license agreement between Seres and the SPN affiliate, less approximately CHF2.0 million in satisfaction of fees due under an existing manufacturing … , subject to the satisfaction or waiver of the conditions set forth therein, to sell our VOWST microbiome therapeutic business
(the “VOWST Business
PREM14A
MCRB
Seres Therapeutics, Inc.
15 Aug 24
Preliminary proxy related to merger
6:52am
as of March 31, 2024 under the existing license agreement between Seres and the SPN affiliate, less approximately CHF2.0 million in satisfaction of fees … agreed, subject to the satisfaction or waiver of the conditions set forth therein, to sell our VOWST microbiome therapeutic business
(the “VOWST
8-K
EX-99.1
MCRB
Seres Therapeutics, Inc.
15 Aug 24
Index to Consolidated Financial Statements
6:05am
concern and that contemplates the realization of assets and satisfaction of liabilities and commitments in the normal course of business. As of December 31 … as of the Effective Date. The fourth and fifth tranches, in an aggregate principal amounts of $25,000 each, were available upon satisfaction of certain
DEFA14A
EX-99.1
blzhrdfar tnh2f
6 Aug 24
Additional proxy soliciting materials
5:28pm
DEFA14A
elv8gvku9g5e0jof
6 Aug 24
Additional proxy soliciting materials
5:28pm
DEFA14A
EX-2.1
afrxuyoyj7qeg 6s6hiw
6 Aug 24
Additional proxy soliciting materials
5:28pm
DEFA14A
EX-99.2
czdd1aj1
6 Aug 24
Additional proxy soliciting materials
5:28pm
DEFA14A
EX-10.1
llfutib 59r
6 Aug 24
Additional proxy soliciting materials
5:28pm
8-K
EX-99.2
75fq w6a7s7rs13
6 Aug 24
Form of Support Agreement
5:27pm
8-K
EX-10.1
30wetgx6d2o9
6 Aug 24
Form of Support Agreement
5:27pm
8-K
EX-99.1
0tk2r
6 Aug 24
Form of Support Agreement
5:27pm
8-K
EX-2.1
0ztxg753i4 m0
6 Aug 24
Form of Support Agreement
5:27pm
8-K
v2npd4nk ah12fifnn
6 Aug 24
Form of Support Agreement
5:27pm